Oberweis Asset Management Inc. boosted its position in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 23.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 59,900 shares of the company's stock after acquiring an additional 11,400 shares during the quarter. Oberweis Asset Management Inc. owned 0.33% of Addus HomeCare worth $7,508,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also bought and sold shares of the company. Natixis grew its position in shares of Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after acquiring an additional 132 shares during the period. Smartleaf Asset Management LLC raised its holdings in Addus HomeCare by 324.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock valued at $35,000 after acquiring an additional 214 shares during the period. Parkside Financial Bank & Trust lifted its position in shares of Addus HomeCare by 38.6% in the fourth quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after acquiring an additional 148 shares in the last quarter. Meeder Asset Management Inc. bought a new position in shares of Addus HomeCare in the fourth quarter worth about $77,000. Finally, Harvest Fund Management Co. Ltd purchased a new position in Addus HomeCare in the 4th quarter worth approximately $86,000. 95.35% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
ADUS has been the subject of several research analyst reports. Stephens reaffirmed an "overweight" rating and set a $142.00 target price on shares of Addus HomeCare in a research note on Wednesday, March 12th. Macquarie reissued an "outperform" rating and issued a $129.00 target price on shares of Addus HomeCare in a report on Thursday, February 27th. StockNews.com cut shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. JMP Securities reiterated a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a research report on Tuesday. Finally, Oppenheimer lifted their target price on Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. One investment analyst has rated the stock with a hold rating, seven have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $139.00.
Check Out Our Latest Report on Addus HomeCare
Addus HomeCare Price Performance
ADUS opened at $98.86 on Thursday. Addus HomeCare Co. has a 1 year low of $88.96 and a 1 year high of $136.72. The firm has a market capitalization of $1.80 billion, a PE ratio of 22.62, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93. The business's 50-day moving average is $98.47 and its two-hundred day moving average is $116.52.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). The business had revenue of $297.14 million for the quarter, compared to analysts' expectations of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. As a group, sell-side analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current year.
Addus HomeCare Profile
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Articles
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.